PCM
ALXN

Prelude Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-124,788
Closed -$22.9M 1917
2021
Q2
$22.9M Buy
124,788
+78,136
+167% +$14.4M 0.68% 2
2021
Q1
$7.13M Buy
46,652
+36,752
+371% +$5.62M 0.18% 30
2020
Q4
$1.55M Buy
9,900
+5,222
+112% +$816K 0.04% 150
2020
Q3
$535K Sell
4,678
-6,496
-58% -$743K 0.03% 280
2020
Q2
$1.25M Buy
11,174
+10,848
+3,328% +$1.22M 0.07% 124
2020
Q1
$29K Sell
326
-2,247
-87% -$200K ﹤0.01% 584
2019
Q4
$278K Buy
2,573
+1,864
+263% +$201K 0.01% 455
2019
Q3
$69K Sell
709
-11,134
-94% -$1.08M ﹤0.01% 680
2019
Q2
$1.55M Buy
+11,843
New +$1.55M 0.08% 120
2019
Q1
Sell
-124
Closed -$12K 1889
2018
Q4
$12K Buy
+124
New +$12K ﹤0.01% 1011
2018
Q3
Sell
-3,894
Closed -$483K 1797
2018
Q2
$483K Buy
+3,894
New +$483K 0.03% 421
2018
Q1
Sell
-7,683
Closed -$919K 1647
2017
Q4
$919K Buy
+7,683
New +$919K 0.07% 233
2017
Q3
Sell
-12,470
Closed -$1.52M 1862
2017
Q2
$1.52M Buy
12,470
+9,312
+295% +$1.13M 0.14% 134
2017
Q1
$383K Buy
3,158
+2,755
+684% +$334K 0.04% 335
2016
Q4
$49K Buy
+403
New +$49K 0.01% 1011
2016
Q2
Sell
-775
Closed -$108K 1741
2016
Q1
$108K Sell
775
-4,482
-85% -$625K 0.02% 676
2015
Q4
$1M Buy
5,257
+636
+14% +$121K 0.16% 138
2015
Q3
$723K Buy
4,621
+186
+4% +$29.1K 0.11% 197
2015
Q2
$802K Sell
4,435
-901
-17% -$163K 0.11% 198
2015
Q1
$925K Buy
5,336
+3,441
+182% +$597K 0.13% 187
2014
Q4
$351K Sell
1,895
-200
-10% -$37K 0.05% 396
2014
Q3
$347K Buy
2,095
+328
+19% +$54.3K 0.05% 461
2014
Q2
$276K Sell
1,767
-3,381
-66% -$528K 0.04% 533
2014
Q1
$783K Buy
5,148
+1,176
+30% +$179K 0.1% 214
2013
Q4
$528K Hold
3,972
0.09% 301
2013
Q3
$461K Sell
3,972
-6,000
-60% -$696K 0.07% 276
2013
Q2
$920K Buy
+9,972
New +$920K 0.2% 97